Classification of a carcinoma of either bladder urothelial carcinoma or prostate adenocarcinoma reaches 100% accuracy by a combination of gene expressions of uroplakin II, S100P, NKX3.1, and PSA. Here, S100P is linked to bladder transitional cell carcinoma.